Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

No known treatment has showed significant long-term remission that is strong enough to declare a Lupus patient as cured. That was, until now.

Today, biotech experts at the French medical research company, Neovacs, are on the brink of a true landmark medical breakthrough. At Neovacs, the focus is not on drug treatment. Instead, Neovacs believes in the therapeutic philosophy of the body’s own immunity. (In other words, enhancing the immunity of the patient to develop an adequate response to fight disease.) It is currently in the advanced clinical trial stage of a therapeutic injectable vaccine for Lupus whose clinical trial results have been nothing short of astounding: Complete remission of symptoms for years, no side effects, no secondary treatments needed, and best of all, a remarkably strong immune system.

Watch The Balancing Act and see why experts are saying a cure for Lupus is, quite iterally, imminent.

Don’t move! The Balancing Act is back with a new Behind the Mystery segment and an inside look at a Broadway sensation.

We're discussing Alport syndrome, a rare, genetic, and chronic kidney condition characterized by declining kidney function which can lead to end-stage kidney disease.

When it comes to facial and body rejuvenation, discover a patient-first, non-surgical approach at Jupiter Plastic Surgery Center.

Comments

comments